期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 277, 期 1-2, 页码 6-12出版社
ELSEVIER
DOI: 10.1016/j.jneuroim.2014.10.011
关键词
Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy; T-cell receptor excision circles; K-deleting recombination excision circles; T-cell receptor repertoire
Natalizumab-induced progressive multifocal leukoencephalopathy appears to be unleashed by complex interactions between viral and immunological host factors leading the latent form of JC virus to become pathogenic. Positive anti-JC virus antibody status, prior use of immunosuppressants, and increasing duration of natalizumab treatment have been proposed as risk factors for progressive multifocal leukoencephalopathy in multiple sclerosis patients, but while they may help to identify the most appropriate patients for natalizumab, their use have some limitations. Therefore, a large body of studies is ongoing to identify alternative, reliable immunological markers capable to improve the safety and efficacy of therapy, and to guide tailored clinical decisions. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据